These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3187194)

  • 1. Biovailability and pulmonary first-pass removal of etretinate in rats.
    Thongnopnua P; Zimmerman CL
    Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):269-72. PubMed ID: 3187194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies.
    Brouwer KR; McNamara PJ
    Drug Metab Dispos; 1989; 17(6):652-5. PubMed ID: 2575502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of presystemic elimination of trichloroethylene and its nonlinear kinetics in rats.
    Lee KM; Bruckner JV; Muralidhara S; Gallo JM
    Toxicol Appl Pharmacol; 1996 Aug; 139(2):262-71. PubMed ID: 8806842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol.
    Raleigh SM; Verschoyle RD; Bowskill C; Pastorino U; Staniforth JN; Steele F; Dinsdale D; Carthew P; Lim CK; Silvester J; Gescher A
    Br J Cancer; 2000 Oct; 83(7):935-40. PubMed ID: 10970697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prehepatic and hepatic first-pass metabolism of lorcainide in rats.
    Plänitz V; Grönniger J; Jähnchen E
    Arzneimittelforschung; 1985; 35(6):923-6. PubMed ID: 4026917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a new pulmonary cyclosporine a powder formulation for prevention of transplant rejection in rats.
    Zijlstra GS; Wolting J; Prop J; Petersen AH; Hinrichs WL; Uges DR; Kerstjens HA; van der Bij W; Frijlink HW
    J Heart Lung Transplant; 2009 May; 28(5):486-92. PubMed ID: 19416778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of administration of moderate doses of etretinate (RO 10-9359) on rats deficient in vitamin A].
    Taruoura D; Higueret P; Suberville C; Higueret D; Garcin H
    Acta Vitaminol Enzymol; 1985; 7(3-4):229-37. PubMed ID: 4091153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-independent pharmacokinetics of clindamycin after intravenous and oral administration to rats: contribution of gastric first-pass effect to low bioavailability.
    Yang SH; Lee MG
    Int J Pharm; 2007 Mar; 332(1-2):17-23. PubMed ID: 17157458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability.
    Chung HJ; Lee JH; Woo SJ; Park HK; Koo CH; Lee MG
    Biopharm Drug Dispos; 2007 May; 28(4):187-97. PubMed ID: 17377948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the deconvolution principle in the estimation of absorption and pre-systemic intestinal elimination of drugs.
    Pithavala YK; Soria I; Zimmerman CL
    Drug Metab Dispos; 1997 Nov; 25(11):1260-5. PubMed ID: 9351902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low oral bioavailability of hexamethylmelamine in the rat due to simultaneous hepatic and intestinal metabolism.
    Klippert PJ; Hulshoff A; Mingels MJ; Hofman G; Noordhoek J
    Cancer Res; 1983 Jul; 43(7):3160-4. PubMed ID: 6406053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of route of administration on the pharmacokinetics of etretinate in the dog.
    Bornemann LD; Cotler S; Khoo KC; Carbone JJ; Colburn WA
    Biopharm Drug Dispos; 1988; 9(1):119-26. PubMed ID: 2963666
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
    Plänitz V; Jähnchen E
    Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal and hepatic first-pass elimination of 2',3'-dideoxyinosine in rats.
    Bramer SL; Au JL; Wientjes MG
    J Pharmacol Exp Ther; 1993 May; 265(2):731-8. PubMed ID: 8496819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and presystemic hepatic first-pass elimination of a novel sigma receptor antagonist, DuP 734, in the rat.
    Kapil RP; Lam GN
    Drug Metab Dispos; 1995 May; 23(5):603-6. PubMed ID: 7587939
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability.
    Yang SH; Lee MG
    Biopharm Drug Dispos; 2008 Oct; 29(7):414-26. PubMed ID: 18697186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presystemic elimination of the beta-blocker pafenolol in the rat after oral and intraperitoneal administration and identification of a main metabolite in both rats and humans.
    Lennernäs H; Renberg L; Hoffmann KJ; Regårdh CG
    Drug Metab Dispos; 1993; 21(3):435-40. PubMed ID: 8100498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chlorphentermine pretreatment on chlorphentermine uptake by isolated perfused rat lung.
    Angevine LS; Ohmiya Y; Mehendale HM
    Drug Metab Dispos; 1982; 10(1):68-73. PubMed ID: 6124387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of a chemoprotective agent, 2-(allylthio)pyrazine, after intravenous and oral administration to rats: hepatic and gastric first-pass effects.
    Han KS; Lee MG
    Drug Metab Dispos; 1999 Feb; 27(2):221-6. PubMed ID: 9929506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.